Stifel analyst J. Bruce Chan maintains ArcBest (NASDAQ:ARCB) with a Buy and lowers the price target from $159 to $150.
Stifel Maintains Buy on ArcBest, Lowers Price Target to $150
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.